跳至主要内容
临床试验/NCT03257514
NCT03257514已完成2 期

Assessing The Effect of Alpha Lipoic Acid on Uterine Scar Healing After Cesarean Section by Using Saline Contrast Sonohysterography

Ain Shams University1 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2017年6月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
102
试验地点
1
主要终点
presence of scar niche

研究概览

简要总结

The aim of this study is to evaluate the efficacy of alpha lipoic acid on uterine scar healing after cesarean section by using saline contrast sonohysterography

详细描述

This is a triple blind randomized placebo controlled prospective clinical trial that will be conducted in Ain Shams University Maternity Hospital.

in which a consecutive series of participant attending emergency room 102 women undergoing cesarean section for the first time will be randomized into two groups.

Group A (Study group): 51 women will receive alpha lipoic acid drug ( 600 mg twice daily) for 6 weeks after cesarean section and saline sonohysterography will be done after that.

Group B (Control group): 51 women will receive a placebo drug twice daily for 6 weeks after cesarean section and saline sonohysterography will be done after that.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Term pregnancy (gestational age between 37-41 weeks).
  • Women undergoing cesarean section for the first time.
  • Normal vaginal ultrasound examination and exclusion of any pelvic abnormality.
  • Uncomplicated cesarean section.
  • Lower uterine segment cesarean sections while the women not in labor.

排除标准

  • Women with complications during or after cesarean section as intrapartum or postpartum hemorrhage, puerperal sepsis, septic wound
  • Women with medical diseases that can affect the healing as diabetes mellitus, anemia, chronic renal disease or hepatic disease or coagulopathy or receiving medications affect wound healing as corticosteroids or anticoagulant.
  • Women who will use intrauterine device as a contraceptive method
  • Women with uterine abnormality as cervical stenosis or fibroid uterus
  • Women with pelvic infection at the time of saline sonohysterography

研究组 & 干预措施

alpha lipoic acid

Active Comparator

51 women will receive alpha lipoic acid drug (thiotacid film coated tablets 600 mg) for 6 weeks after cesarean section then uterine scar healing will be assessed by saline sonohysterography (by placing catheter in the cervical os helping to administering saline into uterine cavity then using the transvaginal ultrasound to view the uterus in the longitudinal view)

干预措施: alpha lipoic acid drug (thioctic acid acid) (Drug)

placebo

Placebo Comparator

51 women will receive a placebo drug for 6 weeks after cesarean section then uterine scar healing will be assessed by saline sonohysterography(by placing catheter in the cervical os helping to administering saline into uterine cavity then using the transvaginal ultrasound to view the uterus in the longitudinal view)

干预措施: Placebo Oral Tablet (Drug)

结局指标

主要结局

presence of scar niche

时间窗: six weeks after CS

triangular shaped anechoic area at the site of incision

The healing ratio

时间窗: six weeks after CS

the thickness of residual myometrium covering the defect divided by the sum of the thickness of residual myometrium cover the defect and the height of wedge shaped defect

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Radwa Rasheedy Ali

lecturer

Ain Shams University

研究点 (1)

Loading locations...

相似试验